Trimedyne Inc (TMED) financial statements (2021 and earlier)

Company profile

Business Address 5 HOLLAND BLDG, #223
IRVINE, CA 92618
State of Incorp. NV
Fiscal Year End September 30
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
9/30/2015
Q4
6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments0100111
Cash and cash equivalents0100111
Short-term investments    000
Receivables0000001
Inventory, net of allowances, customer advances and progress billings2122222
Inventory2122222
Prepaid expense    000
Other current assets0000000
Other undisclosed current assets    (0)(0)(0)
Total current assets:2223333
Noncurrent Assets
Property, plant and equipment0000111
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Other noncurrent assets0000000
Total noncurrent assets:1111111
TOTAL ASSETS:3344444
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1111111
Accounts payable0000000
Accrued liabilities0000001
Taxes payable0000000
Debt0000000
Deferred revenue and credits0000000
Other liabilities    000
Other undisclosed current liabilities000000(0)
Total current liabilities:1111111
Noncurrent Liabilities
Long-term debt and lease obligation   0000
Long-term debt, excluding current maturities   0000
Liabilities, other than long-term debt0000000
Customer advances or deposits    000
Deferred revenue and credits0000000
Other undisclosed noncurrent liabilities    (0)(0)(0)
Total noncurrent liabilities:0000000
Total liabilities:1111111
Stockholders' equity
Stockholders' equity attributable to parent3333333
Common stock0000000
Treasury stock, value(1)(1)(1)(1)(1)(1)(1)
Additional paid in capital51515151515151
Accumulated deficit(48)(48)(48)(48)(48)(48)(47)
Total stockholders' equity:3333333
TOTAL LIABILITIES AND EQUITY:3344444

Income statement (P&L) ($ in millions)

6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
9/30/2015
Q4
6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
Revenues0010100
Revenue, net111 111
Cost of revenue
(Cost of Goods and Services Sold)
(1)(1)(1)(1)(1)(1)(1)
Other undisclosed gross profit1111111
Gross profit:0000000
Operating expenses(1)(1)(1)(1)(1)(1)(1)
Operating loss:(0)(0)(0)(0)(0)(0)(0)
Nonoperating income (expense)(0)0(0)(0)(0)0(0)
Other nonoperating income00     
Interest and debt expense(0) (0)(0)(0)(0)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes0 00000
Loss from continuing operations before income taxes:(0)(0)(0)(0)(0)(0)(0)
Income tax expense(0)(0)(0)(0)(0)(0)(0)
Net loss available to common stockholders, diluted:(0)(0)(0)(0)(0)(0)(0)

Comprehensive Income ($ in millions)

6/30/2016
Q3
3/31/2016
Q2
12/31/2015
Q1
9/30/2015
Q4
6/30/2015
Q3
3/31/2015
Q2
12/31/2014
Q1
Net loss:(0)(0)(0)(0)(0)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(0)(0)(0)(0)(0)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: